FDA Expands Emergency Use of Gilead’s Remdesivir


Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospitalized COVID-19 patients.

The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery time. Patients with more moderate COVID-19 were shown in studies to have modest benefit after being given the drug, according to a study published last week.

Read more at NEWSMAX.



Please enter your comment!
Please enter your name here